Assisted Reproductive Technology Market Size, Share & Outlook | Latest Advancements 2024-2032

Assisted Reproductive Technology Market Synopsis

Assisted Reproductive Technology Market Size Was Valued at USD 27.3 Billion in 2023, and is Projected to Reach USD 46.5 Billion by 2032, Growing at a CAGR of 6.1% From 2024-2032.

Assisted Reproductive Technology (ART) therefore refers to the process of medical intervention to deal with infertility with an aim of helping patients have a child. They include gamete manipulation, which encompasses techniques that are applied on eggs, sperm, and embryos to allow higher probabilities of fertilization and pregnancy. Some of the most general ART techniques are IVF, which is the practice of fertilizing eggs via sperm outside the body and implanting them into the uterus; ICSI, that involves the injection of a single sperm cell into an egg; and the use of donor eggs or sperm. It also consists of cryopreservation, which refers to storage of eggs, sperms or embryos at very low temperatures for later use. These technologies are applicable to those with medical complications that prevent conception, biological age barriers, or undiagnosed causes of infertility; thereby opening up a plethora of opportunities in creating a family.

The technological expansion, new product development, and the strategic M&As by the market’s key players are likely to drive the growth of this industry in the foreseeable future. For instance, In December 2021, CooperCompanies acquired Generate Life Sciences Cologne Company following the full acquisition of its share. Generate Life Sciences is worth it this world for providing donor’s eggs and sperms for the fertility treatments. The transaction has been estimated to be equivalent to USD 1. 6 billion and can be expected to support CooperCompanies in fertility lines.

There are some of the trends that the major drivers of the industry during the forecast period include the cases of infertility, which continues to rise, improved success rates in ART, and the aspect of disposable income in the developing countries.

Several organizations, including the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology, are trying to bring more attention to the available infertility treatments. Moreover, there are some new developments in culture media for ART that are currently carrying out in the following ways. For instance, in the case of CooperSurgicals, they have discovered that culture media with Granulocyte-macrophage Colony-Stimulating Factor (GM-CSF) consists of nutrients necessary for the growth of an embryo and offers a catalytic medium for the message transfer between the embryo and the endometrium, which helps in creating the right environment for pregnancy.

The growth of assisted reproductive technology is seems to due to the primarily contributing factors like growing incidence of infertility due to change in lifestyle or due to increasing stress factors among the general populace, and secondly due to enhanced support offered by respective governments towards fertility treatments. Additionally, introduction of complex aided reproductive technologies like ICSI and fecund, IUI and GIFT, and FET, backed by powerful clinical evidences are also fueling the market growth of fertility services.

Assisted Reproductive Technology Market Trend Analysis

Rising cases of infertility

• Globally, infertility is on the rise and this trend comes with a high likelihood of boosting the consumption of the latest technology that is ART in the next year. This is particularly due to various factors including shift in the lifestyle, delayed child bearing and health complications that contribute to infertility, making couples to opt for assisted reproductive technology (ART) solutions like IVF, and ICSI to start a family. This demand is therefore expected to increase due to improved recognition of the ART types available, improved technology in the execution of ART and the general social acceptance of the treatments. As a result couples seeking fertility treatments, there is an increase in the number of fertility clinics/ healthcare providers that are developing their capacity to delivering ART, thus fueling the market growth.

Increasing disposable income in developing countries

• The global economic growth, especially among developing countries, will also lead to a higher disposable income which will further the consumption of Assisted Reproductive Technology (ART) in the next year. As discrete consumption increases, more people and couples get an ability to pay for usually expensive ART processes including IVF and other related treatments. With this financial capacity, they can go for complex infertility treatments that they would not afford under other circumstances. Moreover, improved income status improves feasibility and acceptability of ART, besides enhancing ones ability to access health/ fertility facilities that offer the services. Therefore, the developments in the ART market of the developing countries indicate that population possesses better financial capability to spend on fertility treatments.

Assisted Reproductive Technology Market Segment Analysis:

Assisted Reproductive Technology Market Segmented based on Technique, Procedure, and End-user.

By Procedure, Fresh Non-donor segment is expected to dominate the market during the forecast period

• When it comes to procedure, the fertility services market can be bifurcated into fresh donor, fresh non-donor, frozen donor, and frozen non-donor. It is expected that the fresh non-donor segment holds higher growth rate CAGR during the forecast period. In particular, the rise of infertility rates on the global level and the high effectiveness of procedures carried out with fresh eggs or embryos contribute to the domination of this segment.

By End-use, fertility clinics & other facilities segment held the largest share in 2023

• Based on the applications, this global industry has been split between fertility clinics & other facilities and hospitals & other settings. Out of the total industry size in year 2022, the largest market share was occupied by the fertility clinics & other facilities end-use segment. Baker Hughes’ segment is expected to increase at this fastest growth rate and maintain its leading industry position by the forecasted period. The high share and its increasing trend stem from an increased incidence of infertility and the absence of any place to conduct ART.
• For example, in the same month of the year 2021, West Asian fertility organization Gulf Capitals ART Fertility Clinis planned to spend USD 31. 3 million in establishing eighteen clinics in significant Indian states by 2023. Moreover, the cost impact, nature of specialization, dedicated expertise in the area, and the flexibility to employ a specific approach for treating the patients form the known factors that may help the segment evolve during the forecast period. The Hospitals & other settings end use segment is expected to show theIDI growth in the subsequently low & middle-income countries due to lack ofinfrastructure to establish fertility clinics & hence the most viable option is inMultispecialty hospitals for treatment of infertility.

Assisted Reproductive Technology Market Regional Insights:

Europe is Expected to Dominate the Market Over the Forecast period

• The global electric vehicles battery market was dominated by Europe in 2022 and held the largest revenue share. The high share is as a result of the increased rate in infertiligy, enhanced awareness of fertility treatments; technologies, and government support. For example, European Society of Human Reproduction and Embryology estimate that in the European Union Population a quarter of people suffer from infertility, and this is the highest recorded in the world. Out of all the above-mentioned regions, North America is predicted to exhibit considerable growth in the coming years. The increased is as a result of better experiences that have been noted by patients who have undergone this treatment.

Active Key Players in the Assisted Reproductive Technology Market

• Cosmos Biomedical Ltd.
• Microm U.K. Ltd.
• CooperSurgical, Inc.
• FUJIFILM Irvine Scientific
• Cryolab Ltd.
• Vitrolife AB
• European Sperm Bank
• Bloom IVF Centre
• Merck KGaA
• Ferring B.V.
• Other Key Players